Leonard R. Hecker

590 total citations
14 papers, 508 citations indexed

About

Leonard R. Hecker is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Leonard R. Hecker has authored 14 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Leonard R. Hecker's work include Chemical Synthesis and Analysis (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Leonard R. Hecker is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Leonard R. Hecker collaborates with scholars based in United States. Leonard R. Hecker's co-authors include Bruce E. Maryanoff, Patricia Andrade‐Gordon, Michael J. Costanzo, Han‐Cheng Zhang, Jack A. Kauffman, Stephen C. Yabut, Frank J. Villani, Samuel Nortey, Aurora Molinari and Keith T. Demarest and has published in prestigious journals such as Journal of Medicinal Chemistry, Synthesis and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Leonard R. Hecker

14 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonard R. Hecker United States 12 302 240 51 39 35 14 508
Stephen C. Yabut United States 10 205 0.7× 210 0.9× 50 1.0× 23 0.6× 37 1.1× 14 417
J. Adam Willardsen United States 13 479 1.6× 270 1.1× 42 0.8× 31 0.8× 78 2.2× 22 712
Dramane I. Lainé United States 14 238 0.8× 193 0.8× 25 0.5× 50 1.3× 35 1.0× 29 528
Robert V. Moquin United States 14 357 1.2× 224 0.9× 27 0.5× 49 1.3× 98 2.8× 19 568
Moshe Weitzberg United States 15 266 0.9× 242 1.0× 58 1.1× 47 1.2× 62 1.8× 28 638
Peter Chua Canada 11 323 1.1× 443 1.8× 30 0.6× 28 0.7× 111 3.2× 14 766
Shendong Yuan United States 11 176 0.6× 253 1.1× 42 0.8× 37 0.9× 88 2.5× 20 524
Carl Crysler United States 19 325 1.1× 304 1.3× 71 1.4× 53 1.4× 145 4.1× 37 782
Sébastien L. Degorce United Kingdom 13 232 0.8× 265 1.1× 31 0.6× 56 1.4× 100 2.9× 26 505
Mary Pat Beavers United States 17 192 0.6× 408 1.7× 53 1.0× 52 1.3× 63 1.8× 25 729

Countries citing papers authored by Leonard R. Hecker

Since Specialization
Citations

This map shows the geographic impact of Leonard R. Hecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard R. Hecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard R. Hecker more than expected).

Fields of papers citing papers by Leonard R. Hecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard R. Hecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard R. Hecker. The network helps show where Leonard R. Hecker may publish in the future.

Co-authorship network of co-authors of Leonard R. Hecker

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard R. Hecker. A scholar is included among the top collaborators of Leonard R. Hecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard R. Hecker. Leonard R. Hecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Costanzo, Michael J., Harold R. Almond, Leonard R. Hecker, et al.. (2007). In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S1‘ Subsite and Its Implications to Structure-Based Drug Design.. Journal of Medicinal Chemistry. 50(23). 5868–5868. 1 indexed citations
2.
Zhang, Han‐Cheng, Hong Ye, Barbara R. Conway, et al.. (2004). 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3. Bioorganic & Medicinal Chemistry Letters. 14(12). 3245–3250. 57 indexed citations
3.
Matthews, Jay M., Alexey B. Dyatkin, Diane A. Gauthier, et al.. (2004). Synthesis, resolution, and absolute configuration of novel tricyclic benzodiazepines. Tetrahedron Asymmetry. 15(8). 1259–1267. 17 indexed citations
4.
Matthews, Jay M., William J. Hoekstra, Alexey B. Dyatkin, et al.. (2004). Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templates. Bioorganic & Medicinal Chemistry Letters. 14(11). 2747–2752. 17 indexed citations
5.
Zhang, Han‐Cheng, Claudia K. Derian, David F. McComsey, et al.. (2004). Novel Indolylindazolylmaleimides as Inhibitors of Protein Kinase C-β:  Synthesis, Biological Activity, and Cardiovascular Safety. Journal of Medicinal Chemistry. 48(6). 1725–1728. 54 indexed citations
6.
Costanzo, Michael J., Harold R. Almond, Leonard R. Hecker, et al.. (2004). In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S1‘ Subsite and Its Implications to Structure-Based Drug Design. Journal of Medicinal Chemistry. 48(6). 1984–2008. 54 indexed citations
7.
Matthews, Jay M., Michael N. Greco, Leonard R. Hecker, et al.. (2003). Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(4). 753–756. 30 indexed citations
8.
Hecker, Leonard R., William J. Hoekstra, Cynthia A. Maryanoff, et al.. (2000). An Expedient Method for Resolution of 3-Amino-3-(3‘-pyridyl)propionic Acid and Related Compounds. Organic Process Research & Development. 5(1). 23–27. 10 indexed citations
9.
McComsey, David F., Leonard R. Hecker, Patricia Andrade‐Gordon, Marylyn M. Addo, & Bruce E. Maryanoff. (1999). Macrocyclic hexapeptide analogues of the thrombin receptor (PAR-1) activation motif SFLLRN. Bioorganic & Medicinal Chemistry Letters. 9(2). 255–260. 11 indexed citations
10.
Hoekstra, William J., Bruce E. Maryanoff, Bruce P. Damiano, et al.. (1999). Potent, Orally Active GPIIb/IIIa Antagonists Containing a Nipecotic Acid Subunit. Structure−Activity Studies Leading to the Discovery of RWJ-53308. Journal of Medicinal Chemistry. 42(25). 5254–5265. 60 indexed citations
11.
Costanzo, Michael J., Bruce E. Maryanoff, Leonard R. Hecker, et al.. (1996). Potent Thrombin Inhibitors That Probe the S1‘ Subsite:  Tripeptide Transition State Analogues Based on a Heterocycle-Activated Carbonyl Group. Journal of Medicinal Chemistry. 39(16). 3039–3043. 61 indexed citations
12.
Greco, Michael N., Leonard R. Hecker, Patricia Andrade‐Gordon, et al.. (1996). Novel thrombin inhibitors that are based on a macrocyclic tripeptide motif. Bioorganic & Medicinal Chemistry Letters. 6(24). 2947–2952. 14 indexed citations
13.
Villani, Frank J., James N. Plampin, Leonard R. Hecker, et al.. (1988). A Versatile Synthesis of NovelN,N,N″-Trisubstituted Guanidines. Synthesis. 1988(6). 460–466. 35 indexed citations
14.
Villani, Frank J., Larry E. Weaner, Leonard R. Hecker, et al.. (1988). Improved Procedures for the Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas. Synthesis. 1988(6). 456–459. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026